SUTRO BIOPHARMA, INC. Contracts & Agreements
55 Contracts & Agreements
- Business Finance (19 contracts)
- Business Operations (3)
- Human Resources (6)
- Intellectual Property (5)
- Real Estate (2)
- Uncategorized (20)
- Exclusive License Agreement between the Registrant and Ipsen Pharma SAS (Filed With SEC on May 13, 2024)
- Underwriting Agreement dated April 2, 2024 (Filed With SEC on April 2, 2024)
- Description of Registrants Securities (Filed With SEC on March 25, 2024)
- Offer Letter, dated August 28, 2013, by and between the Registrant and Hans-Peter Gerber (Filed With SEC on March 25, 2024)
- Severance and Change in Control Plan of the Company (Filed With SEC on March 25, 2024)
- Offer Letter, dated January 18, 2023, by and between the Registrant and Anne E. Borgman (Filed With SEC on March 25, 2024)
- Amended and Restated 2021 Equity Inducement Plan and forms of award agreements thereunder (Filed With SEC on March 25, 2024)
- Manufacturing Rights Agreement between the Registrant and Vaxcyte, Inc (Filed With SEC on March 25, 2024)
- Open Market Sale AgreementSM, dated April 2, 2021, by and between Sutro Biopharma, Inc. and Jefferies LLC (Filed With SEC on February 9, 2024)
- Third Amendment to the Vaxcyte License Agreement between the Registrant and Vaxcyte, Inc (Filed With SEC on November 13, 2023)
- Purchase Agreement, dated June 21, 2023, between the Registrant and an affiliate of Blackstone Life Sciences (Filed With SEC on August 10, 2023)
- Consent and Fifth Amendment to Loan and Security Agreement among Oxford Finance LLC, the Lenders (as defined in the certain Loan and Security Agreement, dated as of February 28,... (Filed With SEC on August 10, 2023)
- Consent and Second Amendment to the Loan and Security Agreement among Oxford Finance LLC, the Lenders (as defined in the certain Loan and Security Agreement, dated as of February... (Filed With SEC on May 15, 2023)
- Consent and Third Amendment to Loan and Security Agreement among Oxford Finance LLC, the Lenders (as defined in the certain Loan and Security Agreement, dated as of February 28,... (Filed With SEC on May 15, 2023)
- Consent and Fourth Amendment to Loan and Security Agreement among Oxford Finance LLC, the Lenders (as defined in the certain Loan and Security Agreement, dated as of February 28,... (Filed With SEC on May 15, 2023)
- First Amendment to the Tasly License Agreement (Filed With SEC on August 8, 2022)
- Offer Letter, dated December 11, 2012, by and between the Registrant and Edward C. Albini (Filed With SEC on February 28, 2022)
- Option Agreement, dated October 9, 2021, by and between the Registrant and BioNova Pharmaceuticals Limited (Filed With SEC on February 28, 2022)
- License Agreement, dated December 24, 2021. by and between the Registrant and Tasly Biopharmaceuticals Co., Ltd (Filed With SEC on February 28, 2022)
- Offer Letter, dated May 23, 2021, by and between the Registrant and Jane Chung (Filed With SEC on February 28, 2022)
- Offer Letter, dated December 11, 2015, by and between the Registrant and Arturo Molina (Filed With SEC on February 28, 2022)
- Second Amendment to the Exclusive Patent License and Research Collaboration Agreement (Filed With SEC on November 10, 2021)
- Third Amendment to Lease 888-894 Industrial Road, San Carlos, CA (Filed With SEC on August 9, 2021)
- Severance and Change in Control Plan (Filed With SEC on May 7, 2021)
- Offer Letter, dated August 8, 2018, by and between the Registrant and Linda Fitzpatrick (Filed With SEC on March 18, 2021)
- Severance and Change in Control Plan of the Company (Filed With SEC on March 18, 2021)
- Underwriting Agreement dated December 8, 2020 (Filed With SEC on December 9, 2020)
- Underwriting Agreement dated May 11, 2020 (Filed With SEC on May 12, 2020)
- Description of Registrants Securities (Filed With SEC on March 16, 2020)
- Amended Form of Restricted Stock Unit Agreement under the 2018 Equity Incentive Plan (Filed With SEC on November 8, 2019)
- Amended Form of Performance Stock Unit Agreement under the 2018 Equity Incentive Plan (Filed With SEC on November 8, 2019)
- First Amendment to Loan and Security Agreement dated December 5, 2018 among Oxford Finance LLC, Silicon Valley Bank and the Registrant (Filed With SEC on April 1, 2019)
- Form of Underwriting Agreement (Filed With SEC on September 17, 2018)
- Form of Indemnity Agreement (Filed With SEC on September 17, 2018)
- 2018 Equity Incentive Plan, to become effective on the date immediately prior to the date the registration statement is declared effective, and forms of award agreements (Filed With SEC on September 17, 2018)
- 2018 Employee Stock Purchase Plan, to become effective on the date the registration statement is declared effective, and forms of award agreements (Filed With SEC on September 17, 2018)
- Amended and Restated Collaboration and License Agreement, dated August 2, 2017, by and among Celgene Corporation, Celgene Alpine Investment Company II, LLC, and the Registrant, as... (Filed With SEC on September 17, 2018)
- Amended and Restated Exclusive Agreement, dated October 3, 2007, between The Board of Trustees of The Leland Stanford Junior University and Fundamental Applied Biology, Inc., as... (Filed With SEC on September 17, 2018)
- Exclusive Patent License and Research Collaboration Agreement, dated July 23, 2018, by and between the Registrant and Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.,... (Filed With SEC on September 17, 2018)
- Form of Common Stock Certificate (Filed With SEC on August 29, 2018)
- Third Amended and Restated Investors Rights Agreement, dated May 24, 2018, by and among the Registrant and certain of its stockholders (Filed With SEC on August 29, 2018)
- Omnibus Amendment Agreement, dated July 26, 2018, by and among the Registrant and certain of its stockholders (Filed With SEC on August 29, 2018)
- Form of Warrant to Purchase Shares of Common Stock (Filed With SEC on August 29, 2018)
- Forms of Warrant to Purchase Series C Redeemable Convertible Preferred Stock (Filed With SEC on August 29, 2018)
- Form of Warrant to Purchase Series D-2 Redeemable Convertible Preferred Stock (Filed With SEC on August 29, 2018)
- 2004 Stock Plan, as amended, and forms of award agreements (Filed With SEC on August 29, 2018)
- 2017 Call Option Plan and forms of award agreements (Filed With SEC on August 29, 2018)
- Offer Letter, dated December 29, 2008, by and between the Registrant and William J. Newell, as amended (Filed With SEC on August 29, 2018)
- Offer Letter, dated December 11, 2015, by and between the Registrant and Arturo Molina, as amended (Filed With SEC on August 29, 2018)
- Offer Letter, dated November 12, 2010, by and between the Registrant and Trevor Hallam, as amended (Filed With SEC on August 29, 2018)
- Edgewater Business Park Lease, dated May 18, 2016, by and between the Registrant and HCP, Inc (Filed With SEC on August 29, 2018)
- Standard Industrial/Commercial Multi-Tenant Lease-Net, dated May 18, 2011, by and between the Registrant and Lydia Tseng and/or Alemany Plaza LLC, as amended (Filed With SEC on August 29, 2018)
- License Agreement, dated September 16, 2014, by and between Merck KGaA, Darmstadt, Germany (operating in the United States and Canada under the name EMD Serono) and the... (Filed With SEC on August 29, 2018)
- Loan and Security Agreement, dated August 4, 2017, among Oxford Finance LLC, Silicon Valley Bank, and the Registrant (Filed With SEC on August 29, 2018)
- Common Stock Purchase Agreement, dated July 23, 2018, by and between the Registrant and Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ (Filed With SEC on August 29, 2018)
